Health Catalyst, Inc.
Price Action
Technical Summary
WEAKENINGHealth Catalyst, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 50), indicating performance broadly in line with the market. Earnings contraction of 337% provides fundamental context to the price action. Investors should exercise caution due to high volatility (91% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.60 | +7.70% | ABOVE |
| 50 SMA | $1.43 | +19.87% | ABOVE |
| 100 SMA | $1.53 | +12.13% | ABOVE |
| 150 SMA | $1.83 | -6.26% | BELOW |
| 200 SMA | $2.13 | -19.23% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HCAT in an uptrend right now?
HCAT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is HCAT overbought or oversold?
HCAT's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is HCAT outperforming the market?
HCAT has a Relative Strength (RS) Rating of 50 out of 99. HCAT is performing about average compared to the market.
Where is HCAT in its 52-week range?
HCAT is trading at $1.72, which is 42% of its 52-week high ($4.13) and 24% above its 52-week low ($0.96).
How volatile is HCAT?
HCAT has a Beta of 1.62 and 52-week volatility of 91%. It's more volatile than the S&P 500 - expect bigger swings.